Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.33 BRL | +4.63% |
|
-2.06% | +5.81% |
07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
Official Publications
- Stock Market
- Equities
- JNJ Stock
- JNJB34 Stock
- News Johnson & Johnson
- Official Publications